ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,37%
Bitcoin
61.069,80
0,45%
Brent Oil
82,585
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Miragen Therapeutics Inc (MGEN)

  7. Miragen Therapeutics Inc (MGEN) Notícias

MGEN

Miragen Therapeutics (MGEN)

Miragen Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGEN
DataHoraFonteTítuloCódigoCompanhia
20/06/202318:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
09/05/202317:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202309:29Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202309:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202309:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MGENMiragen Therapeutics Inc
10/03/202319:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MGENMiragen Therapeutics Inc
09/03/202309:25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202318:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
09/02/202314:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MGENMiragen Therapeutics Inc
07/02/202320:46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MGENMiragen Therapeutics Inc
07/02/202320:35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:MGENMiragen Therapeutics Inc
14/11/202209:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MGENMiragen Therapeutics Inc
19/08/202217:35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MGENMiragen Therapeutics Inc
18/08/202217:42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MGENMiragen Therapeutics Inc
16/08/202207:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MGENMiragen Therapeutics Inc
04/02/202210:02Edgar (US Regulatory)Schedule 13gNASDAQ:MGENMiragen Therapeutics Inc
18/11/202108:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MGENMiragen Therapeutics Inc
15/06/202118:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MGENMiragen Therapeutics Inc
14/04/202117:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:MGENMiragen Therapeutics Inc
19/01/202109:00GlobeNewswire Inc.miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansi...NASDAQ:MGENMiragen Therapeutics Inc
05/01/202109:48Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MGENMiragen Therapeutics Inc
15/12/202019:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:MGENMiragen Therapeutics Inc
08/12/202018:12Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:MGENMiragen Therapeutics Inc
06/11/202018:24Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MGENMiragen Therapeutics Inc
24/03/202016:28Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:MGENMiragen Therapeutics Inc
31/10/201918:13Edgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (d/a)NASDAQ:MGENMiragen Therapeutics Inc
15/08/201909:00GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the Robert W. Baird & Co. 2019 Global Healthcare ConferenceNASDAQ:MGENMiragen Therapeutics Inc
12/08/201909:00GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare ConferenceNASDAQ:MGENMiragen Therapeutics Inc
24/07/201909:00GlobeNewswire Inc.Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7thNASDAQ:MGENMiragen Therapeutics Inc
28/05/201917:30GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare ConferenceNASDAQ:MGENMiragen Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGEN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados